Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Improving Chemical Industry Energy Use, Emissions Intensity

Published: Tuesday, July 02, 2013
Last Updated: Tuesday, July 02, 2013
Bookmark and Share
IEA/ICCA/DECHEMA joint report concludes that emerging and breakthrough technologies promise indispensable energy efficiency improvements.

The IEA, ICCA and DECHEMA jointly released today their new roadmap that explores how the chemical industry can further amplify catalysis and other related technology advances to boost energy efficiency in its production processes.

Entitled Energy and GHG Reductions in the Chemical Industry via Catalytic Processes, the report looks at measures needed from the chemical industry, policymakers, investors and academia to achieve the full potential of catalysts for high-volume processes worldwide. The report details the potential impact of continuous improvements, best practices, emerging technologies, and breakthrough advances to cut energy use in 2050 by 13 exajoules and bring down greenhouse gas (GHG) emission rates by 1 gigatonne of CO2 equivalent.

Around 90 per cent of chemical processes involve the use of catalysts –added substances that increase the rate of reaction without being consumed by it – and related processes to enhance production efficiency and reduce energy use, thereby curtailing GHG emission levels.

Maria van der Hoeven, IEA Executive Director, said: “Energy efficiency is the ‘hidden’ fuel that not only reduces consumption but also mitigates threats to energy security from climate change.  This roadmap identifies important measures that, if adopted, could slash by the middle of the century annual energy use and greenhouse-gas emissions that are equivalent to what Germany consumes and emits today.”

The report calls on policymakers to start developing and implementing policies that bestow greater reward for energy efficiency investments and remove barriers for new investments. A long-term policy framework should be created that encourages investments to reinvigorate catalyst and process improvement and R&D for high-energy consuming processes. Energy subsidies that thwart use of energy efficient technology should be stopped, the report recommends.

The report urges better link-up between financial institutions and chemical industries to meet the pressing need for funding during the transition to and upon reaching a lower-carbon business model. The roadmap outlines a clear need for global and regional co-operation on reducing energy and related emissions via industry associations.

Yoshimitsu Kobayashi, who leads energy and climate change efforts at the International Council of Chemical Associations, added: “Among the thousands of chemicals produced each year, 18 of them account for 80 per cent of energy demand in the chemical industry and 75 per cent of greenhouse gas emissions. It is a reality that the industry has made substantial efficiency improvements for this small group of chemicals, but going to the next level for all chemical products will require further development and deployment of emerging technologies.”

Sustainable biomass feedstocks and hydrogen from renewable energy sources offer additional greenhouse gas savings, according to the paper. The challenge for both is the long-term R&D needed to bring down the amount of energy consumed, to harness this technology for broad use.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Company has announced financing of $30 million to support development of novel therapies to treat gram-negative bacterial infections.
Keeping Tumor Growth at Bay
Engineers at Washington University in St. Louis found a way to keep a cancerous tumor from growing by using nanoparticles of the main ingredient in common antacid tablets.
Future of Medicine Could be Found in a Tiny Crystal Ball
A Drexel University materials scientist has discovered a way to grow a crystal ball in a lab. Not the kind that soothsayers use to predict the future, but a microscopic version that could be used to encapsulate medication in a way that would allow it to deliver its curative payload more effectively inside the body.
Improving Delivery of Poorly Soluble Drugs Using Nanoparticles
A technology that could forever change the delivery of drugs is undergoing evaluation by the Technology Evaluation Consortium™ (TEC). Developed by researchers at Northeastern University, the technology is capable of creating nanoparticle structures that could deliver drugs into the bloodstream orally – despite the fact that they are normally poorly soluble.
Faster Drug Discovery?
Startup develops more cost-effective test for assessing how cells respond to chemicals.
New Mechanism of Antitumor Action Identified
A team of UAB researchers and collaborators from the Catalan biotech company Ability Pharmaceuticals (UAB Research Park), have described a new mechanism of anti-tumour action, identified during the study and development of the new drug ABTL0812.
Nanoparticles Deliver Tumor Suppressors to Damaged Livers
UT Southwestern Medical Center chemists have successfully used synthetic nanoparticles to deliver tumor-suppressing therapies to diseased livers with cancer, an important hurdle scientists have been struggling to conquer.
Experimental Combination Surprises with Anti-HIV Effectiveness
A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected.
A New Type of Anticancer Agent
Success in the development of a ?-tubulin specific inhibitor.
Nanoparticles Proven Effective Against Antibiotic-Resistant “Superbugs”
In the ever-escalating evolutionary battle with drug-resistant bacteria, humans may soon have a leg up thanks to adaptive, light-activated nanotherapy developed by researchers at the University of Colorado Boulder.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!